Evidence map›Paper›PMID 40448417›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

A Novel Interaction of Staphylococcal Protein A With Human Fibronectin and Its Implications in Host Cell Adhesion.

S Camaione, W Pansegrau, F Concetti, M Del Vecchio, L Dello Iacono, I Ferlenghi, A G O Manetti, L Manzi, N Norais, A Pellegrini and 3 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

S CamaioneGSK Vaccines, Siena, Italy.
W PansegrauGSK Vaccines, Siena, Italy.ORCID https://orcid.org/0009-0000-1904-8627
F ConcettiGSK Vaccines, Siena, Italy.
M Del VecchioGSK Vaccines, Siena, Italy.
L Dello IaconoGSK Vaccines, Siena, Italy.
I FerlenghiGSK Vaccines, Siena, Italy.
A G O ManettiGSK Vaccines, Siena, Italy.
L ManziGSK Vaccines, Siena, Italy.
N NoraisGSK Vaccines, Siena, Italy.
A PellegriniDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
S SavinoGSK Vaccines, Siena, Italy.
I MargaritGSK Vaccines, Siena, Italy.
G PietrocolaDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID https://orcid.org/0000-0002-7069-8155

Funding

GlaxoSmithKline (GSK)
6 · The paper itself

Abstract

Staphylococcus aureus is the causative agent of serious human health conditions, such as sepsis, endocarditis, and necrotizing pneumonia, as well as less severe clinical manifestations including epithelial and mucosal infections. This pathogen expresses a wide range of surface virulence factors, among which fibronectin-binding proteins play a crucial role in both bacterial adhesion and infection of host cells. Fibronectin is utilized by S. aureus during the early stages of infection to form a protective coating that shields the bacterium from host defenses, facilitating adhesion to the extracellular matrix of host cells and promoting immune evasion and subsequent invasion. S. aureus protein A (SpA) is a key multi-domain cell wall-anchored and secreted molecule that functions to evade the human immune response by non-specifically interacting with Fc and the Fab V

Indexed as

FibronectinsStaphylococcal Protein AStaphylococcus aureusBacterial AdhesionCell AdhesionHumansProtein BindingStaphylococcal InfectionsVirulence FactorsFibronectinsStaphylococcal Protein AVirulence Factorsbacterial adhesionfibronectinmonoclonal antibodyprotein–protein interactionSpAStaphylococcus aureus

Identifiers

PMID40448417
PMCPMC12125616

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.